The year in cardiology 2017: imaging
█ Current Opinion
Victoria Delgado1, Juhani Knuuti2, Sven Plein3, Stephan Achenbach4, and Jeroen J. Bax1*
1Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands;
2Turku PET Centre, University of Turku and Turku University Hospital, Kiinamyllynkatu 4-8, 20520 Turku, Finland;
3Multidisciplinary Cardiovascular Research Centre & Division of Biomedical Imaging, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Clarendon Wing, Leeds General Infirmary, Great George St, Leeds, LS1 3EX, UK; and
4Department of Cardiology, Friedrich-Alexander-Universität, Krankenhausstr. 12, 91054 Erlangen, Germany
This Year in Cardiology 2017 review article provides a broad overview of the novelties published in non-invasive cardiovascular imaging. While it is well established that echocardiography is the imaging technique of first choice to evaluate patients with cardiovascular symptoms, other techniques (nuclear imaging, cardiovascular magnetic resonance, and computed tomography) are needed to image specific-disease characteristics or pathophysiological mechanisms that may impact on the patient’s management. The evidence showing the incremental diagnostic and prognostic value of combination of imaging techniques or fusion imaging is growing exponentially. Advances in non-invasive cardiac imaging have provided important new insights in the pathophysiology of valvular heart disease and cardiomyopathies, risk stratification of patients with suspected coronary artery disease and diagnosis of implanted device- or bioprosthesis-related complications; this article provides an overview of the most relevant articles published in 2017.